MRNA vs PGEN · rev $145.0M vs rev $78.2M
Moderna Inc (MRNA) versus Precigen Inc (PGEN) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Precigen Inc (PGEN) is a biotechnology company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported PGEN revenue for 2026-06-30 was $78.2M. Net income was $12.1M. PGEN currently screens at market cap $419.2M.
MRNA currently screens at market cap $24.52B. PGEN currently screens at market cap $419.2M.
Not investment advice. Open the MRNA and PGEN stock pages for the full models.
Not investment advice.